Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 6
Submit an article Journal homepage
89
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Zoledronic acid for cancer therapy-induced and postmenopausal bone loss

Adam M Brufsky UPMC Cancer Center Magee-Womens Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA 15213, USA +1 412 641 6500; +1 412 641 2296; [email protected]
, MD PhD
Pages 1013-1028 | Published online: 01 Apr 2008

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ronald C Hamdy. (2010) Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass. Drug Design, Development and Therapy 4, pages 321-335.
Read now

Articles from other publishers (4)

Minju Song. (2019) Dental care for patients taking antiresorptive drugs: a literature review. Restorative Dentistry & Endodontics 44:4.
Crossref
Françoise Redini & Dominique Heymann. (2015) Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma. Frontiers in Oncology 5.
Crossref
Allan LiptonMatthew R. SmithGeorgiana K. EllisCarsten Goessl. (2012) Treatment-Induced Bone Loss and Fractures in Cancer Patients Undergoing Hormone Ablation Therapy: Efficacy and Safety of Denosumab. Clinical Medicine Insights: Oncology 6, pages CMO.S8511.
Crossref
Kenji Ishimoto, Keisuke Tachibana, Ikuko Hanano, Daisuke Yamasaki, Hiroki Nakamura, Megumi Kawai, Yasuomi Urano, Toshiya Tanaka, Takao Hamakubo, Juro Sakai, Tatsuhiko Kodama & Takefumi Doi. (2010) Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells. Biochemical Journal 429:2, pages 347-357.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.